330 related articles for article (PubMed ID: 30385870)
1. Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Giebel S; Marks DI; Boissel N; Baron F; Chiaretti S; Ciceri F; Cornelissen JJ; Doubek M; Esteve J; Fielding A; Foa R; Gorin NC; Gökbuget N; Hallböök H; Hoelzer D; Paravichnikova E; Ribera JM; Savani B; Rijneveld AW; Schmid C; Wartiovaara-Kautto U; Mohty M; Nagler A; Dombret H
Bone Marrow Transplant; 2019 Jun; 54(6):798-809. PubMed ID: 30385870
[TBL] [Abstract][Full Text] [Related]
2. Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Giebel S; Boumendil A; Labopin M; Seesaghur A; Baron F; Ciceri F; Esteve J; Gorin NC; Savani B; Schmid C; Wetten S; Mohty M; Nagler A
Ann Hematol; 2019 Oct; 98(10):2389-2398. PubMed ID: 31392462
[TBL] [Abstract][Full Text] [Related]
3. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
[TBL] [Abstract][Full Text] [Related]
4. Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT.
Giebel S; Labopin M; Potter M; Poiré X; Sengeloev H; Socié G; Huynh A; Afanasyev BV; Schanz U; Ringden O; Kalhs P; Beelen DW; Campos AM; Masszi T; Canaani J; Mohty M; Nagler A
Eur J Cancer; 2018 Jun; 96():73-81. PubMed ID: 29679774
[TBL] [Abstract][Full Text] [Related]
5. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Czyz A; Ottmann O; Baron F; Brissot E; Ciceri F; Cornelissen JJ; Esteve J; Gorin NC; Savani B; Schmid C; Mohty M; Nagler A
Cancer; 2016 Oct; 122(19):2941-51. PubMed ID: 27309127
[TBL] [Abstract][Full Text] [Related]
6. Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT.
Czerw T; Labopin M; Giebel S; Socié G; Volin L; Fegueux N; Masszi T; Blaise D; Chaganti S; Cornelissen JJ; Passweg J; Maertens J; Itälä-Remes M; Wu D; Mohty M; Nagler A
Cancer; 2018 Jun; 124(12):2523-2533. PubMed ID: 29603136
[TBL] [Abstract][Full Text] [Related]
7. Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia-A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Eder S; Beohou E; Labopin M; Sanz J; Finke J; Arcese W; Or R; Bonifazi F; Aljurf M; Socié G; Passweg J; Giebel S; Mohty M; Nagler A
Am J Hematol; 2017 Jan; 92(1):18-22. PubMed ID: 27673280
[TBL] [Abstract][Full Text] [Related]
8. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
Pavlů J; Labopin M; Niittyvuopio R; Socié G; Yakoub-Agha I; Wu D; Remenyi P; Passweg J; Beelen DW; Aljurf M; Kröger N; Labussière-Wallet H; Perić Z; Giebel S; Nagler A; Mohty M
J Hematol Oncol; 2019 Oct; 12(1):108. PubMed ID: 31647022
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease.
Bourlon C; Lacayo-Leñero D; Inclán-Alarcón SI; Demichelis-Gómez R
Curr Oncol Rep; 2018 Mar; 20(4):36. PubMed ID: 29577208
[TBL] [Abstract][Full Text] [Related]
10. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A
J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762
[TBL] [Abstract][Full Text] [Related]
11. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).
Candoni A; Rambaldi A; Fanin R; Velardi A; Arcese W; Ciceri F; Lazzarotto D; Lussana F; Olivieri J; Grillo G; Parma M; Bruno B; Sora F; Bernasconi P; Saccardi R; Foà R; Sessa M; Bresciani P; Giglio F; Picardi A; Busca A; Sica S; Perruccio K; Zucchetti E; Diral E; Iori AP; Colombo AA; Tringali S; Santarone S; Irrera G; Mancini S; Zallio F; Malagola M; Albano F; Carella AM; Olivieri A; Tecchio C; Dominietto A; Vacca A; Sorasio R; Orciuolo E; Risitano AM; Leotta S; Cortelezzi A; Mammoliti S; Oldani E; Bonifazi F;
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2388-2397. PubMed ID: 31400502
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.
Pavlů J; Labopin M; Zoellner AK; Sakellari I; Stelljes M; Finke J; Fanin R; Stuhler G; Afanasyev BV; Bloor AJ; Anagnostopoulos A; Mohty M; Giebel S; Nagler A
Cancer; 2017 Jun; 123(11):1965-1970. PubMed ID: 28211939
[TBL] [Abstract][Full Text] [Related]
13. Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Labopin M; Socié G; Beelen D; Browne P; Volin L; Kyrcz-Krzemien S; Yakoub-Agha I; Aljurf M; Wu D; Michallet M; Arnold R; Mohty M; Nagler A
Haematologica; 2017 Jan; 102(1):139-149. PubMed ID: 27686376
[TBL] [Abstract][Full Text] [Related]
14. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
[TBL] [Abstract][Full Text] [Related]
15. Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Eder S; Canaani J; Beohou E; Labopin M; Sanz J; Arcese W; Or R; Finke J; Cortelezzi A; Beelen D; Passweg J; Socié G; Gurman G; Aljurf M; Stelljes M; Giebel S; Mohty M; Nagler A
Am J Hematol; 2017 Oct; 92(10):997-1003. PubMed ID: 28614903
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
[TBL] [Abstract][Full Text] [Related]
17. The role of allogeneic hematopoietic stem cell transplantation in the therapy of patients with acute lymphoblastic leukemia.
Kebriaei P; Poon LM
Curr Hematol Malig Rep; 2012 Jun; 7(2):144-52. PubMed ID: 22410763
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state.
Saadeh SS; Litzow MR
Expert Rev Hematol; 2018 Mar; 11(3):195-207. PubMed ID: 29376437
[TBL] [Abstract][Full Text] [Related]
19. Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission.
Yan CH; Jiang Q; Wang J; Xu LP; Liu DH; Jiang H; Chen H; Zhang XH; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1314-21. PubMed ID: 24747334
[TBL] [Abstract][Full Text] [Related]
20. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
